Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.santini@uniroma1.it
Daniele Santini
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
daniele.santini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2017
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
ONCOTARGET
2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: the EverExt study
SCIENTIFIC REPORTS
2017
Immunotherapy for colorectal cancer: where are we heading?
EXPERT OPINION ON BIOLOGICAL THERAPY
2017
Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study
ONCOTARGET
2017
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis
EUROPEAN JOURNAL OF CANCER
2017
Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting
ANNALS OF ONCOLOGY
2017
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world
GASTRIC CANCER
2017
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough
FUTURE ONCOLOGY
2017
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
BRITISH JOURNAL OF CANCER
2017
Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain
EUROPEAN JOURNAL OF CANCER
2017
Immunotherapeutic approaches for hepatocellular carcinoma
ONCOTARGET
2017
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group
BMC CANCER
2017
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? (vol 23, pg 2313, 2012)
ANNALS OF ONCOLOGY
2017
Developing drugs in cancer-related bone pain
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2017
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2017
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale
EUROPEAN JOURNAL OF CANCER
2017
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib
ONCOTARGET
2017
Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review
ONCOTARGET
2017
The ‘Charter of Rights for Family Caregivers’. The role and importance of the caregiver: an Italian proposal
ESMO OPEN
2017
« prima
< precedente
…
7
8
9
10
11
12
13
14
15
16
17
18
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma